Medical Supply Chain Security Act
Latest action · Mar 2, 2020 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 2, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medical Supply Chain Security Act
This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage.
Cosponsors 5
Members who signed on, in the order they did. Signatures ran from Mar 2, 2020 to Jun 15, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-WI | Mark Pocan | Original | Mar 2, 2020 |
| R-WI | Glenn Grothman | Apr 28, 2020 | |
| R-KS | Roger Marshall | Apr 28, 2020 | |
| R-PA | Brian K. Fitzpatrick | May 27, 2020 | |
| R-MI | John R. Moolenaar | Jun 15, 2020 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 2, 2020 |
Actions 2
Everything that happened, newest first.
- Mar 2, 2020Introduced in House
- Mar 2, 2020Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 41, March 2, 2020, page H1438.
CRS reports 3
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 3
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46304 | COVID-19: China Medical Supply Chains and Broader Trade Issues | Report | Dec 23, 2020 |
| R46507 | FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19 Archived | Report | Sep 1, 2020 |
| R46334 | Selected Health Provisions in Title III of the CARES Act (P.L. 116-136) | Report | Apr 29, 2020 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 3343 | Medical Supply Chain Security Act | Identical bill | Feb 27, 2020 |
| HR 7208 | Medical Supply Chain Security Act | Reintroduced Bill | Mar 25, 2022 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to provide enhanced security for the medical supply chain.
- Short Title(s) as Introduced
- Medical Supply Chain Security Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Mar 2, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.